Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	105.15	2.75	1.34
Graham Fair Price	-8.10	170457.18	185480.64
PEG	54.06	-0.20	-0.43
Price/Book	11.05	0.41	0.37
Price/Cash Flow	206.48	9.66	3.15
Prices/Earnings	37.33	3.45	2.51
Price/Sales	49.33	1.12	0.75
Price/FCF	206.48	9.66	3.15
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-18.21	0.40	0.48
Operating Margin	-29.39	0.13	0.19
ROA	-17.57	0.01	0.01
ROE	0.04	0.03	-19.14
ROIC	0.06	0.03	-52.47
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	-0.11	94.63
Dividends QOQ	0.00	-0.07	-100.00
EBIT QOQ	0.10	-0.46	370.27
EPS QOQ	-0.06	-0.17	-198.95
FCF QOQ	0.42	-0.63	49.37
Revenue QOQ	0.12	-0.24	104.65
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	223.60	255.68	14.35
Days Sales Outstanding (DSO)	45.66	51.89	13.66
Inventory Turnover	0.40	0.35	-12.55
Debt/Capitalization	0.20	0.19	-1.87
Quick Ratio	2.14	2.14	-0.09
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	202970.91	207431.11	2.20
Cash	173879.15	176249.95	1.36
Capex	-10412.75	-3448.03	66.89
Free Cash Flow	23977.67	8879.19	-62.97
Revenue	101176.97	76895.33	-24.00
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	3.44	3.52	2.18
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-2.17	-4.11	-89.04
Naive Interpretation	Member

06 - Financial Health · Bad

Rating